Literature DB >> 16326180

Chronic rhinosinusitis and superantigens.

Kristin A Seiberling1, Leslie Grammer, Robert C Kern.   

Abstract

This article discusses the potential role of bacterial superantigens (SAgs) in chronic rhinosinusitis with nasal polyposis (CRS/NP). First, it briefly describes SAgs, focusing on how they interact with the immune system by binding to T-cell receptors (TCR) and major histocompatibility complex (MHC) class II molecules. Second, it discusses the role of SAgs in other chronic inflammatory diseases.Finally, it presents evidence for the role of SAgs in the pathogenesis and maintenance of CRS/NP focusing on current research and future considerations.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16326180     DOI： 10.1016/j.otc.2005.08.006

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN： 0030-6665            Impact factor:   3.346


  10 in total

1.  Topical antibiotic therapy of chronic rhinosinusitis.

Authors:  Richard H Comstock; Kent Lam; Suzette Mikula
Journal:  Curr Infect Dis Rep       Date:  2010-03       Impact factor: 3.725

Review 2.  The Etiology and Pathogenesis of Chronic Rhinosinusitis: a Review of Current Hypotheses.

Authors:  Kent Lam; Robert Schleimer; Robert C Kern
Journal:  Curr Allergy Asthma Rep       Date:  2015-07       Impact factor: 4.806

3.  Increased risk of psoriasis in patients with chronic rhinosinusitis without nasal polyps: a longitudinal follow-up study using Korean national sample cohort.

Authors:  Hyo Geun Choi; Ho Jun Lee
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-07-27       Impact factor: 2.503

Review 4.  Role of bacterial and fungal biofilms in chronic rhinosinusitis.

Authors:  Andrew Foreman; Sam Boase; Alkis Psaltis; Peter-John Wormald
Journal:  Curr Allergy Asthma Rep       Date:  2012-04       Impact factor: 4.806

Review 5.  Perspectives on the etiology of chronic rhinosinusitis: an immune barrier hypothesis.

Authors:  Robert C Kern; David B Conley; William Walsh; Rakesh Chandra; Atsushi Kato; Anju Tripathi-Peters; Leslie C Grammer; Robert P Schleimer
Journal:  Am J Rhinol       Date:  2008-09-10

6.  Medical therapy reduces microbiota diversity and evenness in surgically recalcitrant chronic rhinosinusitis.

Authors:  Cindy M Liu; Katerina Soldanova; Lora Nordstrom; Michael G Dwan; Owain L Moss; Tania L Contente-Cuomo; Paul Keim; Lance B Price; Andrew P Lane
Journal:  Int Forum Allergy Rhinol       Date:  2013-07-10       Impact factor: 3.858

Review 7.  Fungal disease of the nose and sinuses: an updated overview.

Authors:  Christopher Chang; M Eric Gershwin; George R Thompson
Journal:  Curr Allergy Asthma Rep       Date:  2013-04       Impact factor: 4.806

8.  Bacterial findings in optimised sampling and characterisation of S. aureus in chronic rhinosinusitis.

Authors:  Ulrica Thunberg; Bo Söderquist; Svante Hugosson
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-18       Impact factor: 2.503

9.  Rat model of staphylococcal enterotoxin B-induced rhinosinusitis.

Authors:  Seong-Ki Ahn; Sea-Yuong Jeon; Roza Khalmuratov; Dong-Ju Kim; Jin-Pyeong Kim; Jeong-Jae Park; Dong-Gu Hur
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-03-20       Impact factor: 3.372

Review 10.  Complementary and integrative treatments: rhinosinusitis.

Authors:  Malcolm B Taw; Chau T Nguyen; Marilene B Wang
Journal:  Otolaryngol Clin North Am       Date:  2013-04-28       Impact factor: 3.346
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.